SCHEMBL20685604

SCHEMBL20685604

Cc1ccc2[nH]c3ccc(Cl)cc3c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
KIF11 P52732 3/20 0.55
ACHE P22303 2/20 0.55
GAA P10253 2/20 0.55
HPGD P15428 2/20 0.55
CYP1A2 P05177 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 1/20 0.54
CHUK O15111 1/20 0.53
POLB P06746 1/20 0.50
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 3/20 0.48
MAPT P10636 3/20 0.48
ALOX15 P16050 1/20 0.48
HSD17B10 Q99714 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HTR2A P28223 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2760335 0.90 KIF11 (0.64) LMNAKIF11ACHEGAAHPGD
SCHEMBL345690 0.87 KIF11 (0.67) LMNAKIF11ACHEGAAHPGD
SCHEMBL29362354 0.87 KIF11 (0.67) LMNAKIF11ACHEGAAHPGD
SCHEMBL607827 0.87 CHUK (0.64) LMNAGAAHPGDCYP1A2MEN1
SCHEMBL29453525 0.87 CHUK (0.64) LMNAGAAHPGDCYP1A2MEN1
SCHEMBL14095141 0.86 MEN1 (0.63) LMNAGAAHPGDCYP1A2MEN1
SCHEMBL13828021 0.82 KIF11 (0.62) LMNAKIF11ACHEGAAHPGD
SCHEMBL550449 0.82 CHUK (0.60) LMNAGAAHPGDCYP1A2MEN1
SCHEMBL25583633 0.81 MEN1 (0.56) LMNAKIF11GAAHPGDCYP1A2
SCHEMBL6009586 0.79 KIF11 (0.62) LMNAKIF11ALDH1A1MAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3347355-B1 HETEROTRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS ICAHN SCHOOL MED MOUNT SINAI (US) 2022-07-13 EP disclosed
EP-2943480-B1 PIPERIDINYLCARBAZOLE AS ANTIMALARIAL MERCK PATENT GMBH (DE) 2019-01-30 EP disclosed